長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4516】日本新薬

【4516】日本新薬
製薬。泌尿器、血液内科、オーファンドラッグ。
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 ツムラ 久光製薬


東証プライム
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/13 Q2予 157,000 ↑ +1.9% +4.7% 33,000 ↑ +3.1% +6.5% 33,600 ↑ +3.4% +6.7% 30,000 ↑ +3.4% +22.4%
2025.03 2024/08/07 Q1予 154,000 ↑ +2.7% +2.7% 32,000 ↑ +3.2% +3.2% 32,500 ↑ +3.2% +3.2% 29,000 ↑ +18.4% +18.4%
2025.03 2024/05/10 当初予 150,000 - - - 31,000 - - - 31,500 - - - 24,500 - - -
2024.03 2024/05/10 実 148,255 ↑ +0.9% +2.2% 33,295 ↓ -0.6% +4.0% 33,616 ↓ -1.1% +3.4% 25,851 ↓ -0.6% +3.4%
2024.03 2024/02/09 Q3予 147,000 → 0.0% +1.4% 33,500 → 0.0% +4.7% 34,000 → 0.0% +4.6% 26,000 → 0.0% +4.0%
2024.03 2023/11/13 Q2予 147,000 ↑ +1.4% +1.4% 33,500 ↑ +4.7% +4.7% 34,000 ↑ +4.6% +4.6% 26,000 ↑ +4.0% +4.0%
2024.03 2023/08/10 Q1予 145,000 → 0.0% 0.0% 32,000 → 0.0% 0.0% 32,500 → 0.0% 0.0% 25,000 → 0.0% 0.0%
2024.03 2023/05/11 当初予 145,000 - - - 32,000 - - - 32,500 - - - 25,000 - - -
2023.03 2023/05/11 実 144,175 ↑ +2.3% +7.6% 30,049 ↑ +0.2% +11.3% 30,489 ↑ +0.3% +10.9% 22,812 ↓ -4.9% +6.1%
2023.03 2023/02/10 Q3予 141,000 → 0.0% +5.2% 30,000 → 0.0% +11.1% 30,400 → 0.0% +10.5% 24,000 → 0.0% +11.6%
2023.03 2022/11/10 Q2予 141,000 ↑ +5.2% +5.2% 30,000 ↑ +11.1% +11.1% 30,400 ↑ +10.5% +10.5% 24,000 ↑ +11.6% +11.6%
2023.03 2022/08/09 Q1予 134,000 → 0.0% 0.0% 27,000 → 0.0% 0.0% 27,500 → 0.0% 0.0% 21,500 → 0.0% 0.0%
2023.03 2022/06/30 当初予 134,000 - - - 27,000 - - - 27,500 - - - 21,500 - - -
2022.03 2022/06/30 実 137,484 ↓ -0.0% +1.8% 32,948 ↑ +16.4% +17.7% 33,301 ↑ +11.8% +16.8% 24,986 ↑ +8.4% +19.0%
2022.03 2022/05/11 実 137,547 ↑ +1.9% +1.9% 28,299 ↑ +1.1% +1.1% 29,773 ↑ +4.5% +4.5% 23,044 ↑ +9.7% +9.7%
2022.03 2022/02/10 Q3予 135,000 → 0.0% 0.0% 28,000 → 0.0% 0.0% 28,500 → 0.0% 0.0% 21,000 → 0.0% 0.0%
2022.03 2021/11/10 Q2予 135,000 → 0.0% 0.0% 28,000 → 0.0% 0.0% 28,500 → 0.0% 0.0% 21,000 → 0.0% 0.0%
2022.03 2021/08/10 Q1予 135,000 → 0.0% 0.0% 28,000 → 0.0% 0.0% 28,500 → 0.0% 0.0% 21,000 → 0.0% 0.0%
2022.03 2021/05/14 当初予 135,000 - - - 28,000 - - - 28,500 - - - 21,000 - - -
2021.03 2021/05/14 実 121,885 ↓ -0.9% -3.3% 26,134 ↑ +4.5% +4.5% 26,760 ↑ +4.9% +4.9% 20,702 ↑ +9.0% +9.0%
2021.03 2021/02/08 Q3予 123,000 → 0.0% -2.4% 25,000 → 0.0% 0.0% 25,500 → 0.0% 0.0% 19,000 → 0.0% 0.0%
2021.03 2020/11/05 Q2予 123,000 ↓ -2.4% -2.4% 25,000 → 0.0% 0.0% 25,500 → 0.0% 0.0% 19,000 → 0.0% 0.0%
2021.03 2020/08/11 Q1予 126,000 → 0.0% 0.0% 25,000 → 0.0% 0.0% 25,500 → 0.0% 0.0% 19,000 → 0.0% 0.0%
2021.03 2020/05/13 当初予 126,000 - - - 25,000 - - - 25,500 - - - 19,000 - - -
2020.03 2020/05/13 実 116,637 ↑ +0.5% +0.5% 21,668 ↑ +3.2% +3.2% 22,442 ↑ +2.0% +2.0% 16,866 ↑ +2.2% +2.2%
2020.03 2020/02/05 Q3予 116,000 → 0.0% 0.0% 21,000 → 0.0% 0.0% 22,000 → 0.0% 0.0% 16,500 → 0.0% 0.0%
2020.03 2019/11/06 Q2予 116,000 → 0.0% 0.0% 21,000 → 0.0% 0.0% 22,000 → 0.0% 0.0% 16,500 → 0.0% 0.0%
2020.03 2019/08/07 Q1予 116,000 → 0.0% 0.0% 21,000 → 0.0% 0.0% 22,000 → 0.0% 0.0% 16,500 → 0.0% 0.0%
2020.03 2019/05/13 当初予 116,000 - - - 21,000 - - - 22,000 - - - 16,500 - - -
2019.03 2019/05/13 実 114,716 ↑ +6.2% +6.2% 20,644 ↑ +11.6% +11.6% 21,540 ↑ +13.4% +13.4% 16,302 ↑ +16.4% +16.4%
2019.03 2019/02/06 Q3予 108,000 → 0.0% 0.0% 18,500 → 0.0% 0.0% 19,000 → 0.0% 0.0% 14,000 → 0.0% 0.0%
2019.03 2018/11/06 Q2予 108,000 → 0.0% 0.0% 18,500 → 0.0% 0.0% 19,000 → 0.0% 0.0% 14,000 → 0.0% 0.0%
2019.03 2018/08/07 Q1予 108,000 → 0.0% 0.0% 18,500 - - - 19,000 → 0.0% 0.0% 14,000 → 0.0% 0.0%
2019.03 2018/05/09 当初予 108,000 - - - - - - - 19,000 - - - 14,000 - - -
2018.03 2018/05/09 実 - - - - - - - - - - - - - - - -
2018.03 2018/02/06 Q3予 102,000 → 0.0% +2.5% 17,500 → 0.0% +6.1% 18,000 → 0.0% +5.9% 13,000 → 0.0% +4.0%
2018.03 2017/11/06 Q2予 102,000 ↑ +2.5% +2.5% 17,500 ↑ +6.1% +6.1% 18,000 ↑ +5.9% +5.9% 13,000 ↑ +4.0% +4.0%
2018.03 2017/08/09 Q1予 99,500 → 0.0% 0.0% 16,500 → 0.0% 0.0% 17,000 → 0.0% 0.0% 12,500 → 0.0% 0.0%
2018.03 2017/05/11 当初予 99,500 - - - 16,500 - - - 17,000 - - - 12,500 - - -
2017.03 2017/05/11 実 98,781 ↑ +3.4% +6.2% 15,280 ↑ +13.2% +32.9% 16,244 ↑ +22.1% +36.5% 11,749 ↑ +30.5% +38.2%
2017.03 2017/02/08 Q3予 95,500 → 0.0% +2.7% 13,500 → 0.0% +17.4% 13,300 → 0.0% +11.8% 9,000 → 0.0% +5.9%
2017.03 2016/11/08 Q2予 95,500 ↑ +2.7% +2.7% 13,500 ↑ +17.4% +17.4% 13,300 ↑ +11.8% +11.8% 9,000 ↑ +5.9% +5.9%
2017.03 2016/05/12 当初予 93,000 - - - 11,500 - - - 11,900 - - - 8,500 - - -
2016.03 2016/05/12 実 84,209 ↓ -3.2% -6.4% 8,549 ↓ -8.1% -8.1% 8,952 ↓ -5.8% -5.8% 6,340 ↓ -5.4% -5.4%
2016.03 2016/02/08 Q3予 87,000 → 0.0% -3.3% 9,300 → 0.0% 0.0% 9,500 → 0.0% 0.0% 6,700 → 0.0% 0.0%
2016.03 2015/11/06 Q2予 87,000 ↓ -3.3% -3.3% 9,300 → 0.0% 0.0% 9,500 → 0.0% 0.0% 6,700 → 0.0% 0.0%
2016.03 2015/08/07 Q1予 90,000 → 0.0% 0.0% 9,300 → 0.0% 0.0% 9,500 → 0.0% 0.0% 6,700 → 0.0% 0.0%
2016.03 2015/05/11 当初予 90,000 - - - 9,300 - - - 9,500 - - - 6,700 - - -
2015.03 2015/05/11 実 79,991 ↓ -1.2% -4.8% 8,562 ↑ +0.7% +0.7% 8,928 ↑ +2.6% +2.6% 5,882 ↓ -2.0% -2.0%
2015.03 2015/02/06 Q3予 81,000 → 0.0% -3.6% 8,500 → 0.0% 0.0% 8,700 → 0.0% 0.0% 6,000 → 0.0% 0.0%
2015.03 2014/11/10 Q2予 81,000 ↓ -3.6% -3.6% 8,500 → 0.0% 0.0% 8,700 → 0.0% 0.0% 6,000 → 0.0% 0.0%
2015.03 2014/08/08 Q1予 84,000 → 0.0% 0.0% - - - - 8,700 → 0.0% 0.0% 6,000 → 0.0% 0.0%
2015.03 2014/05/09 当初予 84,000 - - - 8,500 - - - 8,700 - - - 6,000 - - -
2014.03 2014/05/09 実 76,517 - - - 8,038 - - - 8,598 - - - 5,750 - - -
シェア ツイート
ページトップへ戻る